Indian Journal of Law and Legal Research ISSN: 2582-8878 | PIF: 6.605 Indexed at Manupatra, Google Scholar, HeinOnline & ROAD
Indian Journal of Law and Legal Research
- Dec 12, 2021
Sun Pharma - Ranbaxy: Combination Case Study
Sakshi Gupta, Assistant Professor at Maharashtra National Law University Aurangabad
Indian pharmaceutical companies hold considerable advantage over foreign pharmaceutical manufacturers in terms of cost-effectiveness of manufacturing processes as well as research and development.
Sun Pharmaceutical Industries Limited (“Sun Pharma”) and Ranbaxy Laboratories Limited (“Ranbaxy”) set the Indian pharmaceutical industry abuzz with excitement on April 6, 2014 when they released a press statement announcing that they had entered into definitive documents under which Sun Pharma would acquire 100 percent of Ranbaxy.1 The combined entity is now the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India. The scale of operations of the resulting entity is massive, with operations spanning across 65 countries and 47 manufacturing facilities across 5 continents, as well as a sizeable portfolio of specialty and generic products sold across the world, including 629 abbreviated new drug applications. (“ANDAs”)
The Competition Commission of India (“CCI”) by way of its order dated December 5, 2014 approved the Transaction subject to satisfaction of certain conditions. Thus, the transaction has the potential to give rise to a formidable force in pharmaceutical manufacturing leading to wider presence and broader product portfolio. This paper analyzes in detail, the competition law considerations behind the transaction.
- Volume III Issue II
Abbreviation : IJLLR
ISSN: 2582-8878
Website: www.ijllr.com
Accessibility: Open Access
License: Creative Commons 4.0
Submit Manuscript: Click here
All research articles published in The Indian Journal of Law and Legal Research are fully open access. i.e. immediately freely available to read, download and share. Articles are published under the terms of a Creative Commons license which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Disclaimer:
The opinions expressed in this publication are those of the authors . They do not purport to reflect the opinions or views of the IJLLR or its members. The designations employed in this publication and the presentation of material therein do not imply the expression of any opinion whatsoever on the part of the IJLLR.
- Search Menu
- Browse content in Arts and Humanities
- Browse content in Archaeology
- Anglo-Saxon and Medieval Archaeology
- Archaeological Methodology and Techniques
- Archaeology by Region
- Archaeology of Religion
- Archaeology of Trade and Exchange
- Biblical Archaeology
- Contemporary and Public Archaeology
- Environmental Archaeology
- Historical Archaeology
- History and Theory of Archaeology
- Industrial Archaeology
- Landscape Archaeology
- Mortuary Archaeology
- Prehistoric Archaeology
- Underwater Archaeology
- Urban Archaeology
- Zooarchaeology
- Browse content in Architecture
- Architectural Structure and Design
- History of Architecture
- Residential and Domestic Buildings
- Theory of Architecture
- Browse content in Art
- Art Subjects and Themes
- History of Art
- Industrial and Commercial Art
- Theory of Art
- Biographical Studies
- Byzantine Studies
- Browse content in Classical Studies
- Classical Literature
- Classical Reception
- Classical History
- Classical Philosophy
- Classical Mythology
- Classical Art and Architecture
- Classical Oratory and Rhetoric
- Greek and Roman Archaeology
- Greek and Roman Epigraphy
- Greek and Roman Law
- Greek and Roman Papyrology
- Late Antiquity
- Religion in the Ancient World
- Digital Humanities
- Browse content in History
- Colonialism and Imperialism
- Diplomatic History
- Environmental History
- Genealogy, Heraldry, Names, and Honours
- Genocide and Ethnic Cleansing
- Historical Geography
- History by Period
- History of Agriculture
- History of Education
- History of Emotions
- History of Gender and Sexuality
- Industrial History
- Intellectual History
- International History
- Labour History
- Legal and Constitutional History
- Local and Family History
- Maritime History
- Military History
- National Liberation and Post-Colonialism
- Oral History
- Political History
- Public History
- Regional and National History
- Revolutions and Rebellions
- Slavery and Abolition of Slavery
- Social and Cultural History
- Theory, Methods, and Historiography
- Urban History
- World History
- Browse content in Language Teaching and Learning
- Language Learning (Specific Skills)
- Language Teaching Theory and Methods
- Browse content in Linguistics
- Applied Linguistics
- Cognitive Linguistics
- Computational Linguistics
- Forensic Linguistics
- Grammar, Syntax and Morphology
- Historical and Diachronic Linguistics
- History of English
- Language Variation
- Language Families
- Language Acquisition
- Language Evolution
- Language Reference
- Lexicography
- Linguistic Theories
- Linguistic Typology
- Linguistic Anthropology
- Phonetics and Phonology
- Psycholinguistics
- Sociolinguistics
- Translation and Interpretation
- Writing Systems
- Browse content in Literature
- Bibliography
- Children's Literature Studies
- Literary Studies (Modernism)
- Literary Studies (Asian)
- Literary Studies (European)
- Literary Studies (Eco-criticism)
- Literary Studies (Romanticism)
- Literary Studies (American)
- Literary Studies - World
- Literary Studies (1500 to 1800)
- Literary Studies (19th Century)
- Literary Studies (20th Century onwards)
- Literary Studies (African American Literature)
- Literary Studies (British and Irish)
- Literary Studies (Early and Medieval)
- Literary Studies (Fiction, Novelists, and Prose Writers)
- Literary Studies (Gender Studies)
- Literary Studies (Graphic Novels)
- Literary Studies (History of the Book)
- Literary Studies (Plays and Playwrights)
- Literary Studies (Poetry and Poets)
- Literary Studies (Postcolonial Literature)
- Literary Studies (Queer Studies)
- Literary Studies (Science Fiction)
- Literary Studies (Travel Literature)
- Literary Studies (War Literature)
- Literary Studies (Women's Writing)
- Literary Theory and Cultural Studies
- Mythology and Folklore
- Shakespeare Studies and Criticism
- Browse content in Media Studies
- Browse content in Music
- Applied Music
- Dance and Music
- Ethics in Music
- Ethnomusicology
- Gender and Sexuality in Music
- Medicine and Music
- Music Cultures
- Music and Culture
- Music and Religion
- Music and Media
- Music Education and Pedagogy
- Music Theory and Analysis
- Musical Scores, Lyrics, and Libretti
- Musical Structures, Styles, and Techniques
- Musicology and Music History
- Performance Practice and Studies
- Race and Ethnicity in Music
- Sound Studies
- Browse content in Performing Arts
- Browse content in Philosophy
- Aesthetics and Philosophy of Art
- Epistemology
- Feminist Philosophy
- History of Western Philosophy
- Metaphysics
- Moral Philosophy
- Non-Western Philosophy
- Philosophy of Action
- Philosophy of Law
- Philosophy of Religion
- Philosophy of Science
- Philosophy of Language
- Philosophy of Mind
- Philosophy of Perception
- Philosophy of Mathematics and Logic
- Practical Ethics
- Social and Political Philosophy
- Browse content in Religion
- Biblical Studies
- Christianity
- East Asian Religions
- History of Religion
- Judaism and Jewish Studies
- Qumran Studies
- Religion and Education
- Religion and Health
- Religion and Politics
- Religion and Science
- Religion and Law
- Religion and Art, Literature, and Music
- Religious Studies
- Browse content in Society and Culture
- Cookery, Food, and Drink
- Cultural Studies
- Customs and Traditions
- Ethical Issues and Debates
- Hobbies, Games, Arts and Crafts
- Lifestyle, Home, and Garden
- Natural world, Country Life, and Pets
- Popular Beliefs and Controversial Knowledge
- Sports and Outdoor Recreation
- Technology and Society
- Travel and Holiday
- Visual Culture
- Browse content in Law
- Arbitration
- Browse content in Company and Commercial Law
- Commercial Law
- Company Law
- Browse content in Comparative Law
- Systems of Law
- Competition Law
- Browse content in Constitutional and Administrative Law
- Government Powers
- Judicial Review
- Local Government Law
- Military and Defence Law
- Parliamentary and Legislative Practice
- Construction Law
- Contract Law
- Browse content in Criminal Law
- Criminal Procedure
- Criminal Evidence Law
- Sentencing and Punishment
- Employment and Labour Law
- Environment and Energy Law
- Browse content in Financial Law
- Banking Law
- Insolvency Law
- History of Law
- Human Rights and Immigration
- Intellectual Property Law
- Browse content in International Law
- Private International Law and Conflict of Laws
- Public International Law
- IT and Communications Law
- Jurisprudence and Philosophy of Law
- Law and Society
- Law and Politics
- Browse content in Legal System and Practice
- Courts and Procedure
- Legal Skills and Practice
- Primary Sources of Law
- Regulation of Legal Profession
- Medical and Healthcare Law
- Browse content in Policing
- Criminal Investigation and Detection
- Police and Security Services
- Police Procedure and Law
- Police Regional Planning
- Browse content in Property Law
- Personal Property Law
- Study and Revision
- Terrorism and National Security Law
- Browse content in Trusts Law
- Wills and Probate or Succession
- Browse content in Medicine and Health
- Browse content in Allied Health Professions
- Arts Therapies
- Clinical Science
- Dietetics and Nutrition
- Occupational Therapy
- Operating Department Practice
- Physiotherapy
- Radiography
- Speech and Language Therapy
- Browse content in Anaesthetics
- General Anaesthesia
- Neuroanaesthesia
- Browse content in Clinical Medicine
- Acute Medicine
- Cardiovascular Medicine
- Clinical Genetics
- Clinical Pharmacology and Therapeutics
- Dermatology
- Endocrinology and Diabetes
- Gastroenterology
- Genito-urinary Medicine
- Geriatric Medicine
- Infectious Diseases
- Medical Oncology
- Medical Toxicology
- Pain Medicine
- Palliative Medicine
- Rehabilitation Medicine
- Respiratory Medicine and Pulmonology
- Rheumatology
- Sleep Medicine
- Sports and Exercise Medicine
- Clinical Neuroscience
- Community Medical Services
- Critical Care
- Emergency Medicine
- Forensic Medicine
- Haematology
- History of Medicine
- Medical Ethics
- Browse content in Medical Dentistry
- Oral and Maxillofacial Surgery
- Paediatric Dentistry
- Restorative Dentistry and Orthodontics
- Surgical Dentistry
- Browse content in Medical Skills
- Clinical Skills
- Communication Skills
- Nursing Skills
- Surgical Skills
- Medical Statistics and Methodology
- Browse content in Neurology
- Clinical Neurophysiology
- Neuropathology
- Nursing Studies
- Browse content in Obstetrics and Gynaecology
- Gynaecology
- Occupational Medicine
- Ophthalmology
- Otolaryngology (ENT)
- Browse content in Paediatrics
- Neonatology
- Browse content in Pathology
- Chemical Pathology
- Clinical Cytogenetics and Molecular Genetics
- Histopathology
- Medical Microbiology and Virology
- Patient Education and Information
- Browse content in Pharmacology
- Psychopharmacology
- Browse content in Popular Health
- Caring for Others
- Complementary and Alternative Medicine
- Self-help and Personal Development
- Browse content in Preclinical Medicine
- Cell Biology
- Molecular Biology and Genetics
- Reproduction, Growth and Development
- Primary Care
- Professional Development in Medicine
- Browse content in Psychiatry
- Addiction Medicine
- Child and Adolescent Psychiatry
- Forensic Psychiatry
- Learning Disabilities
- Old Age Psychiatry
- Psychotherapy
- Browse content in Public Health and Epidemiology
- Epidemiology
- Public Health
- Browse content in Radiology
- Clinical Radiology
- Interventional Radiology
- Nuclear Medicine
- Radiation Oncology
- Reproductive Medicine
- Browse content in Surgery
- Cardiothoracic Surgery
- Gastro-intestinal and Colorectal Surgery
- General Surgery
- Neurosurgery
- Paediatric Surgery
- Peri-operative Care
- Plastic and Reconstructive Surgery
- Surgical Oncology
- Transplant Surgery
- Trauma and Orthopaedic Surgery
- Vascular Surgery
- Browse content in Science and Mathematics
- Browse content in Biological Sciences
- Aquatic Biology
- Biochemistry
- Bioinformatics and Computational Biology
- Developmental Biology
- Ecology and Conservation
- Evolutionary Biology
- Genetics and Genomics
- Microbiology
- Molecular and Cell Biology
- Natural History
- Plant Sciences and Forestry
- Research Methods in Life Sciences
- Structural Biology
- Systems Biology
- Zoology and Animal Sciences
- Browse content in Chemistry
- Analytical Chemistry
- Computational Chemistry
- Crystallography
- Environmental Chemistry
- Industrial Chemistry
- Inorganic Chemistry
- Materials Chemistry
- Medicinal Chemistry
- Mineralogy and Gems
- Organic Chemistry
- Physical Chemistry
- Polymer Chemistry
- Study and Communication Skills in Chemistry
- Theoretical Chemistry
- Browse content in Computer Science
- Artificial Intelligence
- Computer Architecture and Logic Design
- Game Studies
- Human-Computer Interaction
- Mathematical Theory of Computation
- Programming Languages
- Software Engineering
- Systems Analysis and Design
- Virtual Reality
- Browse content in Computing
- Business Applications
- Computer Games
- Computer Security
- Computer Networking and Communications
- Digital Lifestyle
- Graphical and Digital Media Applications
- Operating Systems
- Browse content in Earth Sciences and Geography
- Atmospheric Sciences
- Environmental Geography
- Geology and the Lithosphere
- Maps and Map-making
- Meteorology and Climatology
- Oceanography and Hydrology
- Palaeontology
- Physical Geography and Topography
- Regional Geography
- Soil Science
- Urban Geography
- Browse content in Engineering and Technology
- Agriculture and Farming
- Biological Engineering
- Civil Engineering, Surveying, and Building
- Electronics and Communications Engineering
- Energy Technology
- Engineering (General)
- Environmental Science, Engineering, and Technology
- History of Engineering and Technology
- Mechanical Engineering and Materials
- Technology of Industrial Chemistry
- Transport Technology and Trades
- Browse content in Environmental Science
- Applied Ecology (Environmental Science)
- Conservation of the Environment (Environmental Science)
- Environmental Sustainability
- Environmentalist Thought and Ideology (Environmental Science)
- Management of Land and Natural Resources (Environmental Science)
- Natural Disasters (Environmental Science)
- Nuclear Issues (Environmental Science)
- Pollution and Threats to the Environment (Environmental Science)
- Social Impact of Environmental Issues (Environmental Science)
- History of Science and Technology
- Browse content in Materials Science
- Ceramics and Glasses
- Composite Materials
- Metals, Alloying, and Corrosion
- Nanotechnology
- Browse content in Mathematics
- Applied Mathematics
- Biomathematics and Statistics
- History of Mathematics
- Mathematical Education
- Mathematical Finance
- Mathematical Analysis
- Numerical and Computational Mathematics
- Probability and Statistics
- Pure Mathematics
- Browse content in Neuroscience
- Cognition and Behavioural Neuroscience
- Development of the Nervous System
- Disorders of the Nervous System
- History of Neuroscience
- Invertebrate Neurobiology
- Molecular and Cellular Systems
- Neuroendocrinology and Autonomic Nervous System
- Neuroscientific Techniques
- Sensory and Motor Systems
- Browse content in Physics
- Astronomy and Astrophysics
- Atomic, Molecular, and Optical Physics
- Biological and Medical Physics
- Classical Mechanics
- Computational Physics
- Condensed Matter Physics
- Electromagnetism, Optics, and Acoustics
- History of Physics
- Mathematical and Statistical Physics
- Measurement Science
- Nuclear Physics
- Particles and Fields
- Plasma Physics
- Quantum Physics
- Relativity and Gravitation
- Semiconductor and Mesoscopic Physics
- Browse content in Psychology
- Affective Sciences
- Clinical Psychology
- Cognitive Neuroscience
- Cognitive Psychology
- Criminal and Forensic Psychology
- Developmental Psychology
- Educational Psychology
- Evolutionary Psychology
- Health Psychology
- History and Systems in Psychology
- Music Psychology
- Neuropsychology
- Organizational Psychology
- Psychological Assessment and Testing
- Psychology of Human-Technology Interaction
- Psychology Professional Development and Training
- Research Methods in Psychology
- Social Psychology
- Browse content in Social Sciences
- Browse content in Anthropology
- Anthropology of Religion
- Human Evolution
- Medical Anthropology
- Physical Anthropology
- Regional Anthropology
- Social and Cultural Anthropology
- Theory and Practice of Anthropology
- Browse content in Business and Management
- Business History
- Business Strategy
- Business Ethics
- Business and Government
- Business and Technology
- Business and the Environment
- Comparative Management
- Corporate Governance
- Corporate Social Responsibility
- Entrepreneurship
- Health Management
- Human Resource Management
- Industrial and Employment Relations
- Industry Studies
- Information and Communication Technologies
- International Business
- Knowledge Management
- Management and Management Techniques
- Operations Management
- Organizational Theory and Behaviour
- Pensions and Pension Management
- Public and Nonprofit Management
- Strategic Management
- Supply Chain Management
- Browse content in Criminology and Criminal Justice
- Criminal Justice
- Criminology
- Forms of Crime
- International and Comparative Criminology
- Youth Violence and Juvenile Justice
- Development Studies
- Browse content in Economics
- Agricultural, Environmental, and Natural Resource Economics
- Asian Economics
- Behavioural Finance
- Behavioural Economics and Neuroeconomics
- Econometrics and Mathematical Economics
- Economic Methodology
- Economic Systems
- Economic History
- Economic Development and Growth
- Financial Markets
- Financial Institutions and Services
- General Economics and Teaching
- Health, Education, and Welfare
- History of Economic Thought
- International Economics
- Labour and Demographic Economics
- Law and Economics
- Macroeconomics and Monetary Economics
- Microeconomics
- Public Economics
- Urban, Rural, and Regional Economics
- Welfare Economics
- Browse content in Education
- Adult Education and Continuous Learning
- Care and Counselling of Students
- Early Childhood and Elementary Education
- Educational Equipment and Technology
- Educational Strategies and Policy
- Higher and Further Education
- Organization and Management of Education
- Philosophy and Theory of Education
- Schools Studies
- Secondary Education
- Teaching of a Specific Subject
- Teaching of Specific Groups and Special Educational Needs
- Teaching Skills and Techniques
- Browse content in Environment
- Applied Ecology (Social Science)
- Climate Change
- Conservation of the Environment (Social Science)
- Environmentalist Thought and Ideology (Social Science)
- Natural Disasters (Environment)
- Social Impact of Environmental Issues (Social Science)
- Browse content in Human Geography
- Cultural Geography
- Economic Geography
- Political Geography
- Browse content in Interdisciplinary Studies
- Communication Studies
- Museums, Libraries, and Information Sciences
- Browse content in Politics
- African Politics
- Asian Politics
- Chinese Politics
- Comparative Politics
- Conflict Politics
- Elections and Electoral Studies
- Environmental Politics
- European Union
- Foreign Policy
- Gender and Politics
- Human Rights and Politics
- Indian Politics
- International Relations
- International Organization (Politics)
- International Political Economy
- Irish Politics
- Latin American Politics
- Middle Eastern Politics
- Political Theory
- Political Methodology
- Political Communication
- Political Philosophy
- Political Sociology
- Political Behaviour
- Political Economy
- Political Institutions
- Politics and Law
- Public Administration
- Public Policy
- Quantitative Political Methodology
- Regional Political Studies
- Russian Politics
- Security Studies
- State and Local Government
- UK Politics
- US Politics
- Browse content in Regional and Area Studies
- African Studies
- Asian Studies
- East Asian Studies
- Japanese Studies
- Latin American Studies
- Middle Eastern Studies
- Native American Studies
- Scottish Studies
- Browse content in Research and Information
- Research Methods
- Browse content in Social Work
- Addictions and Substance Misuse
- Adoption and Fostering
- Care of the Elderly
- Child and Adolescent Social Work
- Couple and Family Social Work
- Developmental and Physical Disabilities Social Work
- Direct Practice and Clinical Social Work
- Emergency Services
- Human Behaviour and the Social Environment
- International and Global Issues in Social Work
- Mental and Behavioural Health
- Social Justice and Human Rights
- Social Policy and Advocacy
- Social Work and Crime and Justice
- Social Work Macro Practice
- Social Work Practice Settings
- Social Work Research and Evidence-based Practice
- Welfare and Benefit Systems
- Browse content in Sociology
- Childhood Studies
- Community Development
- Comparative and Historical Sociology
- Economic Sociology
- Gender and Sexuality
- Gerontology and Ageing
- Health, Illness, and Medicine
- Marriage and the Family
- Migration Studies
- Occupations, Professions, and Work
- Organizations
- Population and Demography
- Race and Ethnicity
- Social Theory
- Social Movements and Social Change
- Social Research and Statistics
- Social Stratification, Inequality, and Mobility
- Sociology of Religion
- Sociology of Education
- Sport and Leisure
- Urban and Rural Studies
- Browse content in Warfare and Defence
- Defence Strategy, Planning, and Research
- Land Forces and Warfare
- Military Administration
- Military Life and Institutions
- Naval Forces and Warfare
- Other Warfare and Defence Issues
- Peace Studies and Conflict Resolution
- Weapons and Equipment
- < Previous chapter
- Next chapter >
13 A Good Strategy for Growth? A Case Study on Merger of Sun Pharma and Ranbaxy
- Published: August 2022
- Cite Icon Cite
- Permissions Icon Permissions
Sun Pharmaceuticals Industries acquiring Ranbaxy Laboratories to be counted as a significant global supplier and leaders of generic medicine. Their deal has been strictly securitized by national and international regulators. Ranbaxy’s four plants were prohibited from selling drugs in USA for reporting false data of loss to seek approval from FDA. Ranbaxy being significantly valued was eyed by two equity funds and one MNC apart from Sun. Ranbaxy’s portfolio of India alone was $2 billion and with a merger valued at $3.2 billion. Ranbaxy’s export revenue is already under stress following regulatory woes in the United States, the company’s biggest export market. Sun Pharma’s efforts towards resolving Ranbaxy’s regulatory issues with the FDA can help the Mumbai-based drug maker reap lucrative results in the coming years. The giant joint venture needs to face the challenge of Competition Commission of India (CCI) approval as it is bigger in assets and turnover than the CCI limit to chalk out an existence in the domestic market.
Signed in as
Institutional accounts.
- Google Scholar Indexing
- GoogleCrawler [DO NOT DELETE]
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
Institutional access
- Sign in with a library card Sign in with username/password Recommend to your librarian
- Institutional account management
- Get help with access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Our books are available by subscription or purchase to libraries and institutions.
- About Oxford Academic
- Publish journals with us
- University press partners
- What we publish
- New features
- Open access
- Rights and permissions
- Accessibility
- Advertising
- Media enquiries
- Oxford University Press
- Oxford Languages
- University of Oxford
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
- Copyright © 2024 Oxford University Press
- Cookie settings
- Cookie policy
- Privacy policy
- Legal notice
This Feature Is Available To Subscribers Only
Sign In or Create an Account
This PDF is available to Subscribers Only
For full access to this pdf, sign in to an existing account, or purchase an annual subscription.
SUN Rises from RANBAXY: Supply Chain Strategy of an Indian Pharmaceutical Company
- First Online: 05 September 2018
Cite this chapter
- Sushmera Manikandan 3 &
- Balan Sundarakani 4
646 Accesses
1 Citations
The case study critically examines the supply chain strategy of ‘SUN pharma’ company and its acquisition strategy of Ranbaxy. The case illustrates the story of the mergers and acquisition from a supply chain theory point of view and thereby states how SUN has moved forward from its regional presence to global expansion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
- Available as EPUB and PDF
- Read on any device
- Instant download
- Own it forever
- Compact, lightweight edition
- Dispatched in 3 to 5 business days
- Free shipping worldwide - see info
- Durable hardcover edition
Tax calculation will be finalised at checkout
Purchases are for personal use only
Institutional subscriptions
BMI. (2017). India Pharmaceuticals & Healthcare Report . Available at https://www.bmiresearch.com/india . Accessed on July 24, 2018.
Chopra, S., & Meindl, P. (2017). Supply Chain Drivers and Metrics. Supply Chain Management, Strategy, Planning and Operation (6th ed.). Upper Saddle River, NJ: Pearson.
Google Scholar
Cohen, S., & Roussel, J. (2015). Strategic Supply Chain Management, 2nd Edition. New York: McGraw-Hill.
Cook, M., & Hagey, R. (2003). “Why Companies Flunk Supply-Chain 101: Only 33 percent Correctly Measure Supply-Chain Performance; Few Use the Right Incentives”, Journal of Business Strategy , vol. 24, no. 4, pp. 35–42.
Article Google Scholar
Directorate General of Commercial Intelligence and Statistics. (2012). http://www.dgciskol.nic.in/data.asp .
IBEF. (2018). Indian Pharmaceutical Industry . Available at https://www.ibef.org/industry/pharmaceuticalindia.aspx . Accessed on July 24, 2018.
Jayashree, D., & Rajesh, D. (2010). “Pharmaceutical Innovation and Generic Challenge: Recent Trends and Causal Factors”, International Journal of Pharmaceutical and Healthcare Marketing , vol. 4, no. 2, pp. 175–190.
Jocelyn, E. M., Andrew, D. T., Abdallah, S. D., & Peter, A. (2006). “Corporate Social Responsibility Strategies Aimed at the Developing World: Perspectives From Bioscience Companies in the Industrialised World”, International Journal of Biotechnology , vol. 8, no. 1/2, pp. 87–89.
Meenakshi, K., & Vinayshil, G. (2010). “Innovation in the Pharmaceutical Industry: Study of Select Parameters”, Journal of Advances in Management Research, vol. 7, no. 1, pp. 127–138.
Papert, M., Rimpler, P., & Pflaum, A. (2016). “Enhancing Supply Chain Visibility in a Pharmaceutical Supply Chain”, International Journal of Physical Distribution & Logistics Management , vol. 46, no. 9, pp. 859–884.
Rao, P. (2008). “The Emergence of the Pharmaceutical Industry in the Developing World and Its Implications for Multinational Enterprise Strategies”, International Journal of Pharmaceutical and Healthcare Marketing , vol. 2, no. 2, pp. 103–116.
Rossetti, C.L., Handfield, R., & Dooley, K.J. (2011). “Forces, Trends, and Decisions in Pharmaceutical Supply Chain Management”, International Journal of Physical Distribution and Logistics Management , vol. 41, no. 6, pp. 601–622.
Shah, N. (2004). “Pharmaceutical Supply Chains: Key Issues and Strategies for Optimisation”, Computers & Chemical Engineering , vol. 28, no. 6/7, pp. 929–941.
Singh, R., Kumar, R., & Kumar, P. (2016). “Strategic Issues in Pharmaceutical Supply Chains: A Review”, International Journal of Pharmaceutical and Healthcare Marketing , vol. 10, no. 3, pp. 234–257.
Sun Pharma. (2017). Available at http://www.sunpharma.com/sites/default/files/annual/Sun%20Pharma%20Annual%20Report-FY17.pdf .
The Economic Times . (2015). Ranbaxy Integration: Sun Pharma May Drop Some Non-strategic Units. Available at http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ranbaxy-integration-sunpharma-may-drop-some-non-strategic-units/articleshow/49615336.cms . Accessed on July 24, 2018.
World Bank. (2017). India Population Pyramid Report . Available at https://www.populationpyramid.net/india/2017/ . Accessed on July 24, 2018.
Download references
Author information
Authors and affiliations.
Swiss Business School, Zurich, Switzerland
Sushmera Manikandan
Faculty of Business, University of Wollongong in Dubai, Dubai, UAE
Balan Sundarakani
You can also search for this author in PubMed Google Scholar
Corresponding author
Correspondence to Sushmera Manikandan .
Editor information
Editors and affiliations.
University of Wollongong in Dubai, Dubai, United Arab Emirates
Arijit Sikdar
Vijay Pereira
Appendix 1: Mission, Vision, and Values of Sun Pharma
( Source Sun Pharma 2017 )
Teaching Note
Synopsis of the Case
Teaching Purpose and Objectives
The case aims to aid teaching concepts and applications of subjects such as Supply Chain strategy, Operations strategy, and Strategic Management and to enrich concepts related but not limited to business Strategy, supply network expansion strategy, competitive analysis and omni - channel strategy.
Discussion Questions and Analysis
Assess the supply chain strategy development process for Sun Pharma and justify their alignment.
Propose an appropriate supply chain strategy that Sun Pharma should play for their products.
Should Sun Pharma focus more on a pull supply chain strategy rather than the current push strategy?
Should Sun Pharma have a cultural adaptation for the expansion of business for the new markets?
Using the theory of ‘Bottom of Pyramid’ by C.K Prahalad, Debate how should Sun Pharma target the Indian rural market by opening up company owned stores in the rural areas?
Did Dilip Shanghvi manage to turn around Ranbaxy after the take over?
What was Sun Pharma’s rationale for acquiring Ranbaxy, despite the troubles faced by Ranbaxy in foreign markets?
Supply chain strategy of any company must be developed in consistency with an organizational strategy and its functional strategies. This process starts from developing the core vision and mission of a company and relate them with the operational implementation aspects. In theory, it consists of strategy formulation, strategy implementation, and strategy evaluation as exhibited in Fig. 7 . The essence of strategy formulation is an assessment of whether an organization is doing the right things and how it can be more effective in what it does. Regular reappraisal of strategy helps management avoid complacency.
( Source Authors)
Supply chain strategy formulation and implementation framework
Students are expected to apply the strategy development theoretical framework of Fig. 7 in the context of Sun Pharma. This can be assessed in terms of Sun Pharma vision, mission, and value proposition statement to be able to see how realistic they are. Once the organizational strategy is generated, this must be translated into its functional strategy in order to evaluate the performance outcomes of its generic and specialty medicines. For sun pharma, its ‘sunology’ idea fits very well to their core value and, therefore, can sustain their competitive advantage very much.
Supply Chain strategy development process starts from identifying the nature of product through product uncertainty and then comparing with the supply chain capabilities as proposed by Chopra and Meindl ( 2017 ) framework. For pharmaceutical products, the uncertainty is somewhat moderate to high and, therefore, the recommended supply chain strategy is to play with a highly responsive supply chain together with little degree of efficiency embedded in the pharma supply chain processes as illustrated in Fig. 8 .
( Source Chopra and Meindl 2017 framework)
Supply chain strategy alignment with product uncertainty
Should Sun Pharma focus more on pull supply chain strategy rather than the current push strategy?
Theoretically, the push supply chain process involves supply delivery in anticipation to any customer order whereas the pull supply chain process is of reacting to the customer order. For pharma company industry in general, pull supply chain strategy ensures ‘just in time’ delivery and this mechanism require distribution capital investment and or 3PL outsourcing. In the case of Sun pharma, the stages are very much into pull from supplier to manufacturer and push from Manufacturer to retailer and pull again from retailer, pharmacies, and clinics to patients as end users. Since supplier orders the medicines to the production units based on raw materials or Active Pharmaceutical Ingredients (API) from various global vendors and local vendors with their ethical purchasing generic operating procedures, pull supply chain ensures more responsiveness and thus lead to a very high supply chain cost. However, for industry leader such as Sun Pharma cost pressures can offset supply chain speed.
Should Sun Pharma have a cultural adaptation for the expansion of business into any new markets?
Yes, very much likely Sun should have a cultural adaptation for any new market such as Africa, Middle East, and South America where cultural requirement place very dominant role for any business’s success. Students, therefore, should be able to relate the cultural differences of these countries or any new markets while proposing recommendations.
Students can be suggested to research about the ‘Bottom of Pyramid’ population through BMI Research, World bank data and Sun Pharma industry performance. According to BMR Research (2017), Fig. 9 below details the population pyramid of Indian in 2017 and the change in the structure of the population between 2017 and 2050. Table below shows the key metrics such as population ratios, the urban/rural split and life expectancy between 1990 and 2025, which needs to be considered to target tapping the bottom of the pyramid demand. Since the purchasing power of the rural segment is less as compared to Urban population, Sun should devise a more Integrated health care services while opening up stores in the urban areas. Perhaps, partnerships with Government, Medical Colleges, Educational Institutions, association of Indian Industry, and other like agencies, Sun Pharma could reach out to the bottom of the pyramid (see Table 2 ).
Source World Bank ( 2017 ) and BMI ( 2017 )
India population pyramid, 2017 (LHS) versus 2050 (RHS).
Yes, very much successful through the takeover. For example, before merge, Ranbaxy used Aqua Logistics services to track and trace the shipments in order to avoid distribution centers at various overseas and domestic locations by keeping track of the current position of the shipment dispatched by it. Since customer is the King or the key success of Ranbaxy in which thousands of Ranbaxy customers from more than 104 countries served more than 4000 Stock Keeping Units (SKUs) manufactured either at Ranbaxy’s manufacturing facilities or at various other outsourced, but coordination found to be difficult among their supply chain stages. After the acquisition, Sun pharma introduced, supply chain integration system provided by SAP, which acts as the digital backbone of the chain providing on line information to the customers and the organization. To enhance global supply chain capability Sun Pharma, used Radio Frequency Identification (RFID) technology replacing their bar coding system in order to track the stocks automatically (Rossetti et al. 2011 ).
The prime factor behind the acquisition was to gain more control on the Indian pharma manufacturing market and thus to become an industry leader in this segment. Other factors for the takeover include impact of low levels of patent protection, price cuts, a preference for generic medicines and low per capita pharmaceutical and healthcare spending will pose headwinds to innovative drug maker like Sun Pharma to capture opportunities in India. While there is an increased prevalence of chronic diseases, the focus on cost-efficiency within the healthcare sector has aided the acquiring process of Ranbaxy. On the other hand, Ranbaxy had faced tough regulatory challenges due to export ban, very low pricing strategy and stringent regulatory requirements moved the company to ‘bearish’ market performance (Cook and Hagey 2003 ). Ranbaxy’s idea of ‘Putting people first’ approach did not work very well. As said, In order to sustain its success and renew its products, Ranbaxy focused on the people behind its products and not on the products. Ranbaxy’s strength was the people, i.e. both employees and customers. The strategy was to recruit locally in host countries who are culturally adopted within the short time in creating multicultural portfolio of human resource skills. As a result, the company had a challenging working environment and tall organizational structure. These are the trouble faced by Ranbaxy which are the rationale for selling the company to Sun pharma to be able to lead the company’s future.
Suggested Websites :
The following websites are good places for students to get on overall understanding of the context.
https://markets.ft.com/data/equities/tearsheet/forecasts?s=RANBAXY:NSI .
http://businessworld.in/article/Sun-Pharma-Acquiring-Growth/16-03-2016-91995/ .
http://www.thehindubusinessline.com/specials/pulse/case-study-sun-sets-on-ranbaxy/article7065610.ece .
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ranbaxy-integration-sun-pharma-may-drop-some-non-strategic-units/articleshow/49615336.cms .
http://www.sunpharma.com/investors/annualreports .
https://www.rankingthebrands.com/Brand-detail.aspx?brandID=5455 .
https://www.bmiresearch.com/india .
Rights and permissions
Reprints and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Manikandan, S., Sundarakani, B. (2019). SUN Rises from RANBAXY: Supply Chain Strategy of an Indian Pharmaceutical Company. In: Sikdar, A., Pereira, V. (eds) Business and Management Practices in South Asia. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-13-1399-8_11
Download citation
DOI : https://doi.org/10.1007/978-981-13-1399-8_11
Published : 05 September 2018
Publisher Name : Palgrave Macmillan, Singapore
Print ISBN : 978-981-13-1398-1
Online ISBN : 978-981-13-1399-8
eBook Packages : Business and Management Business and Management (R0)
Share this chapter
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
- Publish with us
Policies and ethics
- Find a journal
- Track your research
Navigation Menu
Search code, repositories, users, issues, pull requests..., provide feedback.
We read every piece of feedback, and take your input very seriously.
Saved searches
Use saved searches to filter your results more quickly.
To see all available qualifiers, see our documentation .
- Notifications
- International
- Today’s Paper
- Premium Stories
- Express Shorts
- Health & Wellness
- Brand Solutions
Delhi HC slaps Rs 10 lakh cost on Sun Pharma for concealment of facts in trademark infringement case
Sun pharma had moved to restrain dwd pharmaceuticals ltd from infringing on its ‘forzest’ trademark by selling medicines under the trademark ‘folzest’. while forzest is used to target erectile dysfunction, folzest is a multivitamin for pregnant women.
Imposing a cost of Rs 10 lakh for concealment of facts on Sun Pharma, the Delhi High Court on Monday said that not only does such a practice have to be deprecated but it also has to be penalised.
The observation was made in a plea moved by Sun Pharma against DWD Pharmaceuticals Ltd for restraining them from infringing on the former’s ‘FORZEST’ trademark.
The high court in May had granted an interim injunction in favour of Sun Pharma, restraining DWD from selling its medicinal preparations under the impugned mark ‘FOLZEST’.
The plaintiff, Sun Pharma, alleged that it only learnt about DWD’s trademark in May and hence moved the high court, claiming that the adoption of a similar trademark amounts to infringement as also “passing off and unfair competition”.
While FORZEST is a medicine used to target erectile dysfunction in men, FOLZEST is a multivitamin for pregnant women for lowering the risk of pre-term birth.
The defendant, DWD pharma, argued that it had registered the trademark ‘ZEST’ since 1983, and has a family of registered trademarks, with ‘ZEST’ forming a part of them (hereafter referred to as ‘the ZEST Family of Marks’).
DWD claimed that Sun Pharma was aware of not only the registration of the mark ‘ZEST’ in DWD’s favour but also of the other marks registered and used by the defendant. DWD pointed out that Sun Pharma had earlier applied for the registration of the mark ‘EXEZEST’, which was opposed by DWD in 2009, and this matter is still pending adjudication before the Trade Marks Registry.
On Monday, the high court upheld the interim order but ruled against Sun Pharma over the concealment of facts.
A single-judge bench of Justice Navin Chawla said that Sun Pharma “cannot be allowed to escape the consequences of having concealed material facts from this court to obtain an ex-parte order of injunction”.
“Whether with the disclosure of the above-mentioned material facts, the court would have still granted the ad-interim ex-parte order of injunction or not, is not relevant and cannot absolve the plaintiff from the consequences of not making such disclosure of material facts. Such a practice not only has to be deprecated but must also be penalised,” the court said.
The high court thereafter imposed a cost of Rs 10 lakh on Sun Pharma to be deposited with the Delhi High Court Legal Services Committee within two weeks from the date of the judgment, November 22.
DWD argued that Sun Pharma thereafter applied for registration of its mark ‘TRIOLMEZEST’, which was also opposed by them on December 30, 2014, on the same grounds that DWD is the registered proprietor of the ‘ZEST’ Family of Marks. “Even for the subject-mark, that is, ‘FORZEST’, when the predecessor-in-interest of the plaintiff applied for registration, the defendant’s mark ‘FERIZEST’ was cited as a conflicting mark,” it was submitted.
DWD argued that Sun Pharma has not disclosed the reply filed by them before the Trade Mark Registry against the said examination Report. “It is the case of the defendant that the plaintiff has intentionally not disclosed the above facts in its plaint, and is, therefore, guilty of concealing material facts,” the judgment recorded.
DWD asserted that Sun Pharma had approached the high court with “unclean hands by concealing and suppressing material facts and documents”, and is not entitled to be heard on the merits of its claim and the application filed by Sun Pharma for an interim injunction must be dismissed.
Sun Pharma argued that the uses of the two medicines are different and thus, any confusion between the two trademarks can lead to wrongful consumption of the pharmaceutical goods by an unwary consumer, which in turn will lead to disastrous consequences.
On the concealment of information, Sun Pharma submitted that reply submitted by the predecessor-in-interest of Sun Pharma to the examination report of Trade Mark Registry is not relevant to be submitted before the high court as once the registration of a trademark is granted, no reliance can be placed on such correspondence.
Considering the submissions made by both parties, the high court held that material facts were concealed by Sun Pharma. The court also observed that the concealed information would have been relevant to be considered while the interim relief was granted in May.
The court, however, held that in the case of medicines, the right of not only the private litigants but also public interest has to be kept in mind, and, in fact, be given prominence. “Even a remote chance of deception or confusion arising because of similarity in the marks is to be avoided and prevented, as it may led (lead) to disastrous consequences for unwary consumers,” the high court held.
Therefore, despite the “concealment and misstatement” by Sun Pharma, the high court ruled in their favour as it “prima facie” found that the two medicines were “deceptively similar to each other”.
- delhi high court
Moringa leaves, known as a superfood, are packed with essential macronutrients and micronutrients. They contain high amounts of protein, vitamin C, iron, and calcium. Moringa is also rich in antioxidants, which can help reduce inflammation and protect against chronic diseases. It also boosts immune function and aids in weight management.
- CBSE 10th Result 2024 Today Live: CBSE Class X result likely today at cbse.gov.in, DigiLocker 22 mins ago
- HBSE 10th Result 2024 Live Updates: Haryana Board matric result declared at bseh.org.in 24 mins ago
- CBSE 12th Results 2024 Live Updates: Result declared at cbse.gov.in, cbseresults.nic.in; 2025 exam date announced 24 mins ago
- Stock Market Today Live Updates: Nifty hovers around 22,000 mark, Volatility index up 12% 24 mins ago
Best of Express
Buzzing Now
May 13: Latest News
- 01 Hurdler Unnathi talks about ‘cool’ dad, ‘strict’ coach and Olympian mother who mediates
- 02 Ukraine’s first lady makes her premier visit to Belgrade
- 03 Palestinian public sector salaries squeezed as Israel withholds tax revenue
- 04 ‘If ideology is same, why remain separate’: Shashi Tharoor on potential merger of smaller parties into Congress
- 05 Minor boy dies, 5 of his family taken ill after consuming noodles in UP
- Elections 2024
- Political Pulse
- Entertainment
- Movie Review
- Newsletters
- Web Stories
- [email protected]
- 022 6230 8800 / 022 62308801
- Industry Solutions
- Industry Insights
- Insights from Implementation
- Counterpoint Series
- Counterpoint Podcast
- Apparent in Hindsight-the book
- Values & Principles
- Unique Engagement Process
- New Consulting Paradigms
- Restoring business harmony
- Incubator of Start-ups
- News Release
- Meet The Team
- The Vector Way
- Vector Digital Labs
Other Case Studies
Godrej Interio Healthcare
Kirloskar Oil Engines Limited-NPD
Godrej Material Handling
Bajaj Luminaires Division
Schneider Electric
Kirloskar oil engines ltd. (koel).
Godrej Securities Solutions
Godrej Storage Solutions
Kirloskar Oil Engines Ltd (Spares And Services)
Godrej Tooling
Action Construction Equipment Limited - ACE Cranes
Lakshmi Machine Works Ltd. (Machine Tool Division)
Raychem RPG
Filtrum Tools
GMM Pfaudler Ltd
Hercules Hoists Limited
LMW Machine Tool Division (MTD)-New Product Development
L&T – Heavy Engineering
Shanthi Gears
Greaves Cotton Ltd.
International Tractors Limited
Ashok Leyland- Spares Parts Division
Tata Motors-Spare Parts & Services Division (Commercial Vehicles)
Ashok Leyland – NPD
Fleetguard Filters Pvt Ltd
JK Fenner (India) Ltd
Kirloskar Ferrous Industries Ltd (KFIL)
Lucas Indian Service Ltd.
Mahindra First Choice Services
Mahindra First Choice (Spares And Services)
Tata Radiators
Fleetguard Filters Pvt. Ltd. (NPD)
Filtrum Polymers Pvt. Ltd.
Royal Enfield
TVS Motor Company Ltd
Volvo Eicher
Tata Autocomp Systems Ltd
Shriram Pistons
Aditya Auto
Blackberrys
Pratibha Syntex Ltd
Raymond Luxury Cottons Ltd.
A Major Vertically Integrated Linen Exporter
Trident Group (Home Textiles)
Dollar Industries
Arvind Fashions
Dr. Reddy’s Laboratories
Ajanta Pharma
A large generic drug manufacturing company - Quality labs
Bajaj Electricals Engineering And Projects Division
Godrej Electricals & Electronics Division
Skipper Limited
KEI Industries Ltd
Tata Bluescope Steel Limited
Tata Metaliks
Fleetguard Filters
Trident Group
Godrej Security Solutions
Sterlite Technologies Ltd.
Godrej Interiors
Salasar Techno Engg.
Godrej Interio-NPI
Bajaj Electricals Limited (CP)
VIP Industries Ltd
Jindal Stainless Limited
Godrej Megasari
Parag Milk Foods Ltd.
Walkaroo International
Godrej Interio-Home Kitchens
Liberty Shoes Ltd
JK Files And Tools
Godrej Interio- Service And Spares
Liberty Retail Revolution Ltd
Godrej Interio - office furnitures
Skipper Pipes Limited
Sintex Industries Limited
Century Plyboards India Ltd.
Asian Granito
APL Apollo Tubes Limited (APL Apollo)
Vaibhav Global Limited
Kirloskar Agri
Shakti Pumps
Godrej Hershey’s
Future Retail Ltd
Yellow Diamond (Prataap Snacks)
Shalimar Paints
Jindal Stainless Steelway
Bake with Yen
Luminous Power Technologies Pvt. Ltd
TI Cycles of India Ltd
Ambuja Cements
TATA International
Get in touch
In-clinic effectiveness platform for medical representatives.
Introduction
- Sun Pharmaceutical Industries Ltd. is the fourth largest speciality generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion
- Supported by over 36,000 employees and more than 40 manufacturing facilities in the word
- Sun Pharma provides high-quality, affordable medicines in more than 100 countries across the globe
- Difficulty in measuring the in-clinic effectiveness of sales executives
- Reduce onboard time for new sales representatives
- Need of a practise-oriented platform for the sales team
- Getting a holistic overview of the entire sales team’s performance
Approaching the solution
- Awarathon’s interactive and engaging offerings for medical executives and managers helped them to prepare, practice, and perform well in a risk-free controlled environment
- Realistic in-clinic situations were set with a sufficient number of reattempts so that each participant could practice multiple times
- The manual assessment feature allowed each manager to share constructive feedback with their team members
- The learning and development team got to know where their sales representatives were lacking and what aspects of the sales process required improvement so they could re-strategize their sales approach
- Awarathon video assessments were rolled out across multiple divisions. Right from their sales executives to the top management, everyone participated in the assessment
- Awarathon received positive feedback from all the business heads at Sun Pharma. After initially leveraging the platform with just 2 divisions at the pilot stage, Sun Pharma has successfully rolled out the Awarathon for all India business verticals
Difference made
- There has been a significant enhancement in the performance of new hires
- Refinement in the sales pitch and boosted confidence of sales executives has resulted in improved in-clinic effectiveness
- More than 80% adoption from each division
- More than 90% of similarities found between managers’ feedback and real-time AI-enabled reports
Customer Stories
Mankind Pharma’s Journey with AI-Enabled Video Role-Plays
Online transition of sales process due to Covid-19
Standardization and measurement of customer service processes
Alkem Laboratories drives higher sales performance using Awarathon
Structuring onboarding and training processes to support scale-up
A sales enablement platform in alignment with its sales process.
Comprehensive sales readiness platform to revamp sales training.
Multilingual sales enablement for rural consumer finance.
Optimize sales success by aligning learning and upskilling with your goals through Awarathon.
Get in touch and embark on your ai journey today, contact us [email protected], why choose us.
- What Customers Say
- Why Choose Awarathon
- Success Stories
AI-Enabled Sales Simulator (Pitch)
- Role Play Assessment (Perfect)
- Reports and Analytics (Always)
Sales Training
- Financial Services
Life Science
Product video, privacy policy, ai & analytics, data privacy.
- Partnership
Follow Us On
©2024 Awarathon Awareness Initiatives Pvt. Ltd., All Rights Reserved.
Hit enter to search or ESC to close
- AI Enabled Sales Simulator (Pitch)
- Life Sciences
- Awarathon Blog
- Awarathon Product Videos
- GAMP Solutions
- Case studies
- Research Reports
- FAQ’s
Case Study of Sun Pharma – MIS System
Customer story.
Sun Pharmaceutical Industries Ltd. is a multinational pharma company and one of the major players in the generic drug market at Indian and International level, having 40+ manufacturing sites spanning over 6 Continents.
Challenges of MIS Manual Process
- Manually performing financial planning and reporting of their domestic & international operations on excel spreadsheets.
- The finance team will create, distribute multiple excel sheets to hundreds of organizational department users to complete the task and send back to them for budget consolidations, preparing financial statements and reports, etc
- Uncontrolled data, version controls, currency conversion, change in format template, understanding case scenarios, no insight view of users across 70 to 100 countries.
- Lack of workflow made difficult for them to track the status of each end user task with emails, calls and waiting for response where it delays the process.
Management Information System (MIS) Solution
- Single web-based Excel Interface for all the users, Robust workflow, Easy to adopt or use.
- Integration with GL account, SAP or any legacy system for pulling the data.
- Bringing Full control, validations on data, restriction on major information with a specific set of defined users.
- Automatic currency conversions, budget consolidations, connected templates are pre-populated with relevant information based on rows and columns.
- Assign Scheduled reports, deadlines to users, access real-time information for analysis, monitor flow status in real time.
- Detailed audit trail records of all end-user actions, Activity logs.
Results of Management Information System
- Excel functionality remains the same.
- AmpleLogic MIS Solution Generate global P&L reports, cash flow, and fund flow statements, inventory and debtors reports, sales projection, top molecules, capex or opex report and many more.
- Understand and analyze the good and worst test case scenarios.
- Reduce reporting cycle from 4 to 6 months to close in one day at the end of the month with a single click.
- Increased efficiency of all your business operations, reduce costs, no errors, and emails, reduce manual work.
Industry Pharmaceutical Manufacturing
Location, India
Employees, 10K+ employees
Where is your business office? In the India locations.
Time for delivery 35 days
What do you want us to do in this ? We will assure our best services. In this time and in case of any need we will be there for you.
Download detailed case study
Custom applications.
Sales Targeting
Budgeting Software
Management Information System
CAPEX and OPEX
Back Order Management
Enterprise Energy Management
Energy Tracker
Can't find what you're looking for?
BYOA – Build Your Own Applicatio n
Pharma GAMP Solutions
Annual Product Quality Review
Electronic Logbook System
Laboratory Information Management System
Manufacturing Execution System
Asset Management System
Regulatory Information Management System
Learning Management System
Environmental Monitoring System
Electronic Quality Management System
User Access Management System
Document Management System
QC Planning
Quality Control System
Cleaning Validation Software
Process Validation Software
BYOA – Build Your Own Application
COMMENTS
The pharmaceutical company Sun Pharma is manufacturing a new batch of painkiller drugs, which are due for testing. Around 80,000 new products are created and need to be tested for their time of effect (which is measured as the time taken for the drug to completely cure the pain), as well as the quality assurance (which tells you whether the drug was able to do a satisfactory job or not).
SUN PHARMA CASE STUDY NAME: ZULFIKHAR ALI.J Problem statement: The pharmaceutical company Sun Pharma is manufacturing a new batch of painkiller medications, which are due for testing. Around 80,000 new products are created and need to be tested for their time of effect (which is
2 likes • 4,849 views. Affle mTraction Enterprise. Sun Pharma is a leading pharmaceutical company based out in India. They have 45 manufacturing units spanning across 6 continents and a huge number of employed Human Resource. Read more. Technology. 1 of 5. CASE STUDY | Sun Pharma - Download as a PDF or view online for free.
Sun Pharmaceuticals Industries Ltd (Sun Pharma) was established by Mr. Dilip Shanghvi in 1983 in Gujarat with five drugs to treat psychiatry ailments. Cardiology products were introduced in 1987 followed by gastroenterology products in 1989. Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.
Comprehension. The pharmaceutical company Sun Pharma is manufacturing a new batch of painkiller medications, which are due for testing. Around 80,000 new products are created and need to be tested for their time of effect (which is measured as the time taken for the medicine to show effects) as well as quality assurance (which tells you whether the medicine was able to do a satisfactory job).
Sun Pharmaceutical Industries Limited ("Sun Pharma") and Ranbaxy Laboratories Limited ("Ranbaxy") set the Indian pharmaceutical industry abuzz with excitement on April 6, 2014 when they released a press statement announcing that they had entered into definitive documents under which Sun Pharma would acquire 100 percent of Ranbaxy.1 The combined entity is now the fifth-largest specialty ...
Corporate Restructuring in India: A Case Study of Sun Pharmaceutical.... 177 Table 2: Summary of Sun Pharma Pre and Post Ranbaxy Merger (Rs.in Million) Financial Year 2013-14 (Pre-acquisition) Financial Year 2014-15 (Post-acquisition) Net Sales 1,60,044 2,72,865 Gross Profit 1,32,250 2,05,473
Sun Pharma's efforts towards resolving Ranbaxy's regulatory issues with the FDA can help the Mumbai-based drug maker reap lucrative results in the coming years. The giant joint venture needs to face the challenge of Competition Commission of India (CCI) approval as it is bigger in assets and turnover than the CCI limit to chalk out an ...
The case tracks the development of Sun Pharma from its inception in the 1980s to becoming the fifth largest generic pharmaceutical company in the world. It also discusses in detail the recent ...
Abstract. This is one wrestle which has rocked the two crown establishments in pharma space and has taken them through a roller coaster ride. The battalion of group companies for one of India's leading drug maker Sun Pharmaceutical Industries Limited would have swiftly expanded to include another gigantic drug making company of Israel i.e. Taro Pharmaceutical Industries Limited.
A Case Study on Merger of Sun Pharma and Ranbaxy | Case Volume IV brings industry live into the classroom for management students and onto the desks of scholars, managers, and entrepreneurs for ...
The case study critically examines the supply chain strategy of 'SUN pharma' company and its acquisition strategy of Ranbaxy. The case illustrates the story of the mergers and acquisition from a supply chain theory point of view and thereby states how SUN has moved forward from its regional presence to global expansion.
The case study critically examines the supply chain strategy of 'SUN pharma' company and its acquisition strategy of Ranbaxy. The case illustrates the story of the mergers and acquisition from ...
Sun Pharmaceuticals » Case Study - Free download as PDF File (.pdf), Text File (.txt) or read online for free. n
Problem Statement. The pharmaceutical company Sun Pharma is manufacturing a new batch of painkiller drugs, which are due for testing. Around 80,000 new products are created and need to be tested for their time of effect (which is measured as the time taken for the drug to completely cure the pain), as well as the quality assurance (which tells ...
Sanghvi will have to pay ₹62.35 lakh to SEBI and Sun Pharma ₹56 lakh to settle the case. SEBI allows settlement of cases without acceptance or denial of guilt. Related-party deal.
Delhi HC slaps Rs 10 lakh cost on Sun Pharma for concealment of facts in trademark infringement case Sun Pharma had moved to restrain DWD Pharmaceuticals Ltd from infringing on its 'FORZEST' trademark by selling medicines under the trademark 'FOLZEST'. While FORZEST is used to target erectile dysfunction, FOLZEST is a multivitamin for ...
A case study of Vector Consulting Group's work with Sun Pharma from the Life Sciences to facilitate the successful implementation of innovative TOC solutions for their project. [email protected] 022 6230 8800 / 022 62308801; MENU. Industry Solutions; Our Work; Research and Publications.
Sun Pharmaceuticals in 2004 focus on Indian pharmaceutical companies, with their generic drugs have proved their capabilities in the world's largest and most lucrative markets - the U.S and Europe. These companies with their strong reverse engineering skills have gained a foothold in these key markets. Indian top-tier companies such as Dr. Reddy's, Ranbaxy, Cipla, Wockhardt and Sun ...
Sun Pharmaceutical Industries Ltd. is the fourth largest speciality generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion. Supported by over 36,000 employees and more than 40 manufacturing facilities in the word. Sun Pharma provides high-quality, affordable medicines in more than 100 countries across the globe.
Comments. Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.. We have migrated to a new ...
Sun Pharmaceutical Industries Ltd. is a multinational pharma company and one of the major players in the generic drug market at Indian and International level, having 40+ manufacturing sites spanning over 6 Continents. Challenges of MIS Manual Process Manually performing financial planning and reporting of their domestic & international operations on excel spreadsheets. The finance team will...
With the healthcare industry being the most targeted sector in India, pharmaceutical companies must remain vigilant and proactive in their efforts to protect their IT assets and data. Sun Pharma ended Monday 1.15% up at Rs983.95 on the BSE, while the 30-share Sensex closed marginally higher at 57,653.86 points.